Device Trial Radar · NCT02347189
Melody PB1016 Surveillance Study
Last checked: Nov 20, 2026Latest source record: Nov 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39
Actual
Start
Nov 2014
Primary completion
Nov 2016
Study completion Aug 10, 2018
Sponsor
- Lead sponsor
- Medtronic Heart ValvesPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 27, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Non-randomized, multi-center, prospective surveillance study to investigate and assess the residual risks, and to confirm the currently established safety and performance of the Melody TPV PB1016.
Conditions
- Dysfunctional RVOT Conduits in Patients With Congenital Heart Defects
Interventions
Melody Transcatheter Pulmonary Valve PB1016Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Acceptable TPV Hemodynamic Function At 6 MonthsTime frame: 6 Months
Locations
8 sites in 4 countries. Site status is shown where the registry gives one.
University of California - Los Angeles
Los Angeles, California
Children's Hospital of Michigan
Detroit, Michigan
Nationwide Childrens Hospital
Columbus, Ohio
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.